A new trading day began on Friday, with Neumora Therapeutics Inc. (NASDAQ: NMRA) stock price up 1.49% from the previous day of trading, before settling in for the closing price of $12.73. NMRA’s price has ranged from $8.33 to $21.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 58.94%. With a float of $54.86 million, this company’s outstanding shares have now reached $158.83 million.
The firm has a total of 124 workers. Let’s measure their productivity.
Neumora Therapeutics Inc. (NMRA) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Neumora Therapeutics Inc. is 65.49%, while institutional ownership is 27.62%. The most recent insider transaction that took place on Sep 17 ’24, was worth 363,736. In this transaction Head of R&D of this company sold 30,788 shares at a rate of $11.81, taking the stock ownership to the 339,205 shares. Before that another transaction happened on Sep 18 ’24, when Company’s Head of R&D sold 10,676 for $12.09, making the entire transaction worth $129,091. This insider now owns 328,529 shares in total.
Neumora Therapeutics Inc. (NMRA) Earnings and Forecasts
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -1.14 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 58.94% per share during the next fiscal year.
Neumora Therapeutics Inc. (NASDAQ: NMRA) Trading Performance Indicators
Here are Neumora Therapeutics Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 17.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.74, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.60 in one year’s time.
Technical Analysis of Neumora Therapeutics Inc. (NMRA)
Analysing the last 5-days average volume posted by the [Neumora Therapeutics Inc., NMRA], we can find that recorded value of 1.77 million was better than the volume posted last year of 0.63 million. As of the previous 9 days, the stock’s Stochastic %D was 87.17%. Additionally, its Average True Range was 0.68.
During the past 100 days, Neumora Therapeutics Inc.’s (NMRA) raw stochastic average was set at 90.35%, which indicates a significant increase from 89.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.07% in the past 14 days, which was higher than the 54.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.73, while its 200-day Moving Average is $12.85. Now, the first resistance to watch is $13.27. This is followed by the second major resistance level at $13.62. The third major resistance level sits at $14.03. If the price goes on to break the first support level at $12.51, it is likely to go to the next support level at $12.10. Should the price break the second support level, the third support level stands at $11.75.
Neumora Therapeutics Inc. (NASDAQ: NMRA) Key Stats
With a market capitalization of 2.07 billion, the company has a total of 159,524K Shares Outstanding. Currently, annual sales are 0 K while annual income is -235,930 K. The company’s previous quarter sales were 0 K while its latest quarter income was -58,700 K.
